A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment-Reference-Cited by-同舟云学术

A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment

Published:2023-01-02 Issue:1 Volume:62 Page:53-57
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Ong Rina Yue Ling¹^ORCID,Seah Valerie Xue Fen¹^ORCID,Chong Chia Yin²³⁴⁵^ORCID,Thoon Koh Cheng²³⁴⁵^ORCID,Tan Natalie Woon Hui²³⁴⁵^ORCID,Li Jiahui²³⁴⁵,Nadua Karen Donceras²³⁴⁵^ORCID,Soh Shui Yen³⁴⁵⁶^ORCID,Seng Michaela Su-Fern³⁴⁵⁶^ORCID,Pham Thi Ngoc Anh⁷,Yung Chee Fu²⁴⁵^ORCID,Kam Kai-Qian²³⁴⁵^ORCID

Affiliation:

1. Department of Pharmacy, KK Women’s and Children’s Hospital, Singapore, Singapore

2. Infectious Disease Service, Department of Pediatrics, KK Women’s and Children’s Hospital, Singapore, Singapore

3. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

4. Duke-National University of Singapore Medical School, Singapore, Singapore

5. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

6. Haematology/Oncology Service, Department of Pediatrics, KK Women’s and Children’s Hospital, Singapore, Singapore

7. Nursing Clinical Services, Division of Nursing, KK Women’s and Children’s Hospital, Singapore, Singapore

Funder

Singhealth Duke-NUS Academic Medicine COVID-19 Rapid Response Research Grant

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2169079

Reference37 articles.

1. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

2. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults

3. Risk Factors for Severe COVID-19 in Children

4. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

5. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

2. Views and insights into the remdesivir study for the treatment of severe pediatric COVID‐19 cases;Health Science Reports;2024-07

3. A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection;Cytotherapy;2024-05

4. Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care;Viruses;2024-04-26

5. Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection – a single-center, retrospective, cohort study;European Journal of Pediatrics;2023-10-21